newsfilter
← Latest News
Business Wire·

CytRx Notes Topline Data From Trial of Arimoclomol in Amyotrophic Lateral Sclerosis

CytRx Corporation (OTCQB:CYTR) ("CytRx"), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today noted that Orphazyme A/S (NASDAQ:ORPH) ("Orphazyme") announced that th